業績

{ 192件 }

日本内分泌学会 第5回若手臨床内分泌医奨励賞 Runners-Up賞 中田 健人先生

  • 2022
  • 糖尿病・内分泌グループ
  • 受賞

Oral Abstracts Presentation Award of the 17th International Congress on Antiphospholipid Antibodies and the APS Foundation of America 

藤枝 雄一郎  先生

  • 2022
  • 膠原病グループ
  • 受賞

Shindo T, Ito M, Sugiyama T, Okuyama T, Kono M, Atsumi T, Fujimura M.

Diagnostic Value of Vessel Wall Imaging to Determine the Timing of Extracranial-Intracranial Bypass for Moyamoya Syndrome Associated with Active Sjogren's Syndrome: A Case Report J Neurol Surg A Cent Eur Neurosurg, 2022

IF=1.268

  • 2022
  • 膠原病グループ
  • 欧文論文/症例報告

Kato M*#, Kudo Y#, Hatase M, Tsuchida N, Takeyama S, Sugiyama T, Fujimura M, Yabe I, Tsujimoto H, Fukumori Y, Inoue N, Atsumi T.

Moyamoya disease associated with a deficiency of complement component 6.  (*: Correspondence, #: These authors contribute equally to this

work)

Journal of Stroke & Cerebrovascular Diseases. in press

IF:2.136

  • 2022
  • 膠原病グループ
  • 欧文論文/症例報告

66回日本リウマチ学会総会・学術集会 JCR 2022 ICW Excellent Abstract Award 崎山 広大先生

  • 2022
  • 膠原病グループ
  • 受賞

Yamauchi Y, Nakamura A, Yokota T, Takahashi K, Kawata S, Tsuchida K, Omori K, Nomoto H, Kameda H, Cho KY, Anzai T, Tanaka S, Terauchi Y, Miyoshi H, Atsumi T.

Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function.

Sci Rep, in press.

IF: 4.380

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Aika Miya, Akinobu Nakamura, Isao Yokota, Kyu Yong Cho, Hiraku Kameda, Hiroshi Nomoto, Takahiro Takase, Kazuno Omori, Mayuko Ono, So Nagai, Shinji Taneda, Hideaki Miyoshi, Tatsuya Atsumi The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes Geriatrics and Gerontology International, in press

IF: 2.730

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nakamura J, Tsujino I, Ohira H, Nakaya T, Sugimoto A, Sato T, Watanabe T, Suzuki M, Kato M, Yokota I, Konno S.

Various factors contributing to death among patients with different types of pulmonary hypertension: A retrospective pilot study from a single tertiary center.

Respiratory Investigation. in press

  • 2022
  • 膠原病グループ
  • 欧文論文/原著

Nakamura A.

Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic Beta-Cell Mass and Function.

Int J Mol Sci, in press.

IF: 5.924

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/総説

Hiroshi Nomoto, Sho Furusawa, Akinobu Nakamura, Jun Takeuchi, So Nagai, Hiroki Yokoyama, Ichiro Sakuma, Shinji Taneda, Yoshio Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, and Hideaki Miyoshi Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes:

protocol for a multi-center, prospective, randomized, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study) BMJ Open, in press

IF: 2.692

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著